(Q73178077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Susceptibility testing for mycobacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Woods GL

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

6 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1209-1215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

1 November 2019

cites work

1 reference

Respiratory viral infections in immunocompetent and immunocompromised persons

21 January 2018

1 reference

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

21 January 2018

1 reference

Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?

21 January 2018

1 reference

Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system

21 January 2018

1 reference

Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium

21 January 2018

1 reference

Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease

21 January 2018

1 reference

Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population

21 January 2018

1 reference

Rifampin-resistant Mycobacterium kansasii

21 January 2018

1 reference

Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex

21 January 2018

1 reference

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution

21 January 2018

1 reference

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

21 January 2018

1 reference

Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/317441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11073754%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference